Biocon Ltd Fact Sheet, Biocon Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Ltd Fact Sheet    (BICN)

Here is the latest financial fact sheet of Biocon Ltd. For more details, see the Biocon Ltd quarterly results and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 259.6
Mkt Cap Rs m 155,730
Vol '000 114.6
P/E X 19.4
P/CF X 19.1
EPS (TTM) Rs 13.4
% ch % 0.5
No. of shares m 600.00
% ch week % 4.9
% ch 1-mth % 13.9
% ch 12-mth % -21.2
52 week H/L Rs 341.5/211.3
(As on Oct 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
BIOCON  EQUITY SHARE DATA
High Rs4975544961,1621,188 
Low Rs265407397483305 
Sales per share (Unadj.) Rs143.9154.5167.4194.668.7 
Earnings per share (Unadj.) Rs20.724.930.534.47.6 
Diluted earnings per shareRs6.98.310.211.57.6 
Cash flow per share (Unadj.) Rs30.935.942.948.314.0 
Dividends per share (Unadj.) Rs5.005.005.001.001.00 
Adj. dividends per shareRs1.671.671.670.331.00 
Dividend yield (eoy) %1.31.01.10.10.1 
Book value per share (Unadj.) Rs151.3163.1201.7241.986.3 
Adj. book value per shareRs50.454.467.280.686.3 
Shares outstanding (eoy) m200.00200.00200.00200.00600.00 
Bonus/Rights/Conversions  ----IS 
Price / Sales ratio x2.63.12.74.210.9 
Avg P/E ratio x18.419.314.623.998.9 
P/CF ratio (eoy) x12.313.410.417.053.4 
Price / Book Value ratio x2.52.92.23.48.6 
Dividend payout %24.220.116.42.913.2 
Avg Mkt Cap Rs m76,19096,08089,220164,440447,900 
No. of employees `0007.37.54.49.26.1 
Total wages/salary Rs m4,6635,3346,1017,4709,311 
Avg. sales/employee Rs Th3,936.14,119.77,581.94,213.96,705.8 
Avg. wages/employee Rs Th637.9711.21,381.9809.01,514.2 
Avg. net profit/employee Rs Th566.1663.21,379.6745.2736.9 
BIOCON  INCOME DATA
Net Sales Rs m28,77330,89833,47438,91141,234 
Other income Rs m5595317921,5712,062 
Total revenues Rs m29,33231,42934,26640,48243,296 
Gross profit Rs m6,8716,9587,6789,7958,291 
Depreciation Rs m2,0362,2102,4872,7723,851 
Interest Rs m1789293260615 
Profit before tax Rs m5,3775,1905,6908,3345,887 
Minority Interest Rs m-170-310217163213 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m01,0511,60600 
Tax Rs m1,0699571,4221,6161,569 
Profit after tax Rs m4,1384,9746,0916,8814,531 
Gross profit margin %23.922.522.925.220.1 
Effective tax rate %19.918.425.019.426.7 
Net profit margin %14.416.118.217.711.0 
BIOCON  BALANCE SHEET DATA
Current assets Rs m26,38824,75039,70940,47741,486 
Current liabilities Rs m13,79615,97416,65716,78321,413 
Net working cap to sales %43.828.468.960.948.7 
Current ratio x1.91.52.42.41.9 
Inventory Days Days4856596064 
Debtors Days Days7681788394 
Net fixed assets Rs m27,30834,16940,14645,07350,661 
Share capital Rs m1,0001,0001,0001,0003,000 
"Free" reserves Rs m27,04731,62239,33847,37748,808 
Net worth Rs m30,26732,62240,33848,37751,808 
Long term debt Rs m6,0627,67120,72421,08217,898 
Total assets Rs m57,50663,31984,58193,94299,897 
Interest coverage x317.359.320.433.110.6 
Debt to equity ratio x0.20.20.50.40.3 
Sales to assets ratio x0.50.50.40.40.4 
Return on assets %7.28.07.57.65.2 
Return on equity %13.715.215.114.28.7 
Return on capital %14.414.912.812.69.6 
Exports to sales %37.133.5000 
Imports to sales %22.819.7000 
Exports (fob) Rs m10,66910,339000 
Imports (cif) Rs m6,5736,102000 
Fx inflow Rs m10,80310,99311,61412,98812,058 
Fx outflow Rs m7,7157,3718,1827,8997,348 
Net fx Rs m3,0883,6223,4325,0894,710 
BIOCON  CASH FLOW
From Operations Rs m 5,607 2,107 3,706 6,400 6,621 
From Investments Rs m -9,381 -5,087 -11,417 -4,985 -6,840 
From Financial Activity Rs m 4,260 1,862 10,676 -1,775 -2,397 
Net Cashflow Rs m 486 -1,118 3,000 -473 -2,612 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 20.6%
Indian inst/Mut Fund 8.4%
FIIs 10.7%
ADR/GDR 0.0%
Free float 19.9%
Shareholders 109,995
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
E-MAIL kiran.kumar@biocon.com WEB www.biocon.com
TELEPHONE (080) 2808 2037 FAX (080) 2852 3423
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.4

More Pharmaceuticals Company Fact Sheets:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  

Compare BIOCON With:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Views on news

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

MORE ON BIOCON

COMPARE BIOCON WITH

MARKET STATS